PROPANC BIOPHARMA, INC. Shareholders' Equity
PROPANC BIOPHARMA, INC. (PPCB) had Shareholders' Equity of $9.83 million as of 2026-03-31, per its S-1 filed 2026-07-17.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-07-17
- 2026-03-31: Stockholders' Equity Attributable to Parent $9.83M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $10.45M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $14.36M.
- 2025-06-30: Stockholders' Equity Attributable to Parent $13.91M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-03-31 | $9.83M S-1 · filed 2026-07-17 | |
| 2025-12-31 | $10.45M S-1 · filed 2026-07-17 | |
| 2025-09-30 | $14.36M S-1 · filed 2026-07-17 | |
| 2025-06-30 | $13.91M S-1 · filed 2026-07-17 | |
| 2025-03-31 | $18.09M S-1 · filed 2026-07-17 | |
| 2024-12-31 | -$4.16M S-1 · filed 2026-07-17 | |
| 2024-09-30 | -$4.11M S-1 · filed 2026-07-17 | |
| 2024-06-30 | -$3.78M S-1 · filed 2026-07-17 | |
| 2024-03-31 | -$3.70M 10-Q · filed 2025-05-15 | |
| 2023-12-31 | -$3.56M 10-Q · filed 2025-05-15 | |
| 2023-09-30 | -$2.99M 10-Q · filed 2025-05-15 | |
| 2023-06-30 | -$3.12M S-1 · filed 2026-07-17 | |
| 2023-03-31 | -$2.94M 10-Q · filed 2024-05-15 | |
| 2022-12-31 | -$2.92M 10-Q · filed 2024-05-15 | |
| 2022-09-30 | -$2.77M 10-Q · filed 2024-05-15 | |
| 2022-06-30 | -$3.02M 10-K · filed 2024-09-30 | |
| 2022-03-31 | -$2.95M 10-Q · filed 2023-05-15 | |
| 2021-12-31 | -$2.93M 10-Q · filed 2023-05-15 | |
| 2021-09-30 | -$2.31M 10-Q · filed 2023-05-15 | |
| 2021-06-30 | -$3.07M 10-K · filed 2023-09-28 | |
| 2021-03-31 | -$3.00M 10-Q · filed 2022-05-16 | |
| 2020-12-31 | -$3.61M 10-Q · filed 2022-05-16 | |
| 2020-09-30 | -$3.24M 10-Q · filed 2022-05-16 | |
| 2020-06-30 | -$3.64M 10-K · filed 2022-09-28 | |
| 2020-03-31 | -$4.85M 10-Q · filed 2021-05-14 | |
| 2019-12-31 | -$5.67M 10-Q · filed 2021-05-14 | |
| 2019-09-30 | -$4.54M 10-Q · filed 2021-05-14 | |
| 2019-06-30 | -$4.30M 10-K · filed 2021-09-28 | |
| 2019-03-31 | -$3.41M 10-Q · filed 2020-05-15 | -$3.41M 10-Q · filed 2019-05-15 |
| 2018-12-31 | -$3.90M 10-Q · filed 2020-05-15 | |
| 2018-09-30 | -$5.56M 10-Q · filed 2020-05-15 | |
| 2018-06-30 | -$6.75M 10-K · filed 2020-10-01 | |
| 2018-03-31 | -$6.77M 10-Q · filed 2019-05-15 | |
| 2017-12-31 | -$7.15M 10-Q · filed 2019-05-15 | |
| 2017-09-30 | -$6.74M 10-Q · filed 2019-05-15 | |
| 2017-06-30 | -$5.44M 10-K · filed 2019-10-15 | |
| 2017-03-31 | -$4.71M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | -$3.84M 10-Q · filed 2017-02-14 | |
| 2016-09-30 | -$1.80M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | -$2.57M 10-K · filed 2018-09-17 | |
| 2016-03-31 | -$3.52M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | -$3.36M 10-Q · filed 2016-02-16 | |
| 2015-09-30 | -$3.18M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | -$3.05M 10-K · filed 2017-09-28 | |
| 2015-03-31 | -$1.85M 10-Q · filed 2015-05-15 | |
| 2014-12-31 | -$1.88M 10-Q · filed 2015-02-17 | |
| 2014-09-30 | -$1.78M 10-Q · filed 2014-11-19 | |
| 2014-06-30 | -$1.41M 10-K · filed 2016-09-28 | |
| 2014-03-31 | -$1.17M 10-Q · filed 2014-05-20 | |
| 2013-12-31 | -$1.05M 10-Q · filed 2014-02-14 | |
| 2013-09-30 | -$1.22M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | -$792.48K 10-K · filed 2015-09-30 | |
| 2013-03-31 | -$747.84K 10-Q · filed 2013-05-20 | |
| 2012-12-31 | -$643.22K 10-Q · filed 2013-02-20 | |
| 2012-09-30 | -$609.64K 10-Q · filed 2012-11-19 | |
| 2012-06-30 | -$537.92K 10-K · filed 2014-10-14 | |
| 2012-03-31 | $1.68M 10-Q · filed 2012-05-21 | |
| 2011-12-31 | $4.52M 10-Q/A · filed 2012-03-07 | |
| 2011-06-30 | $10.51M 10-K · filed 2013-10-15 | |
| 2010-06-30 | -$186.90K 10-K · filed 2013-10-15 | |
| 2009-06-30 | -$409.39K 10-K · filed 2013-10-15 | |
| 2008-06-30 | $85.13K 10-K · filed 2013-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |